GSK plc ADR buy Guggenheim
Start price
04.03.24
/
50%
€38.80
Target price
04.03.25
-
Performance (%)
-7.22%
End price
05.03.25
€36.00
Summary
This prediction ended on 05.03.25 with a price of €36.00. With a performance of -7.22%, the BUY prediction by Guggenheim finished with a loss. A total of €1.45 was paid as dividends for this prediction. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| GSK plc ADR | -1.339% | -1.339% | 35.583% |
| iShares Core DAX® | 0.184% | 5.072% | 8.979% |
| iShares Nasdaq 100 | -0.770% | -2.079% | 26.437% |
| iShares Nikkei 225® | 0.733% | -3.346% | 47.887% |
| iShares S&P 500 | -0.166% | 0.904% | 22.974% |
Comments by Guggenheim for this prediction
In the thread GSK plc ADR diskutieren
GSK plc (NYSE: GSK) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating.
Ratings data for GSK provided by MarketBeat
In the thread Trading GSK plc ADR
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten